Antigen-specific immune effector cells
US12163155B2 · kind B2 · utility
0Cited by
26References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 18, 2018 |
| Grant date | Dec 10, 2024 |
| Priority date | — |
| Expiry date | Nov 15, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2510/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods for the production of antigen-specific effector T cells and NK cells from pluripotent stem cells which express a chimeric antigen receptor (CAR). Further provided herein are methods for the adoptive cell therapy by administering the effector T cells and/or NK cells provided herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.